Document is current
Any future updates will be listed below
-
Authors
Duque-Afonso, Jesús https://orcid.org/0000-0002-8287-5673
Finke, Jürgen https://orcid.org/0000-0002-1799-5927
Ngoya, Maud
Galimard, Jacques-Emmanuel https://orcid.org/0000-0001-9102-4427
Craddock, Charles https://orcid.org/0000-0001-5041-6678
Raj, Kavita https://orcid.org/0000-0002-8258-354X
Bloor, Adrian
Nicholson, Emma https://orcid.org/0000-0002-6439-0795
Eder, Matthias
Kim, Orchard
Valerius, Thomas https://orcid.org/0000-0001-9181-8067
Snowden, John A. https://orcid.org/0000-0001-6819-3476
Tholouli, Eleni
Crawley, Charles
Collin, Matthew
Wilson, Keith M. O. https://orcid.org/0000-0002-6327-9366
Gadisseur, Alain
Protheroe, Rachel
Wagner-Drouet, Eva Maria https://orcid.org/0000-0002-0728-2253
Savani, Bipin N. https://orcid.org/0000-0002-3304-9965
Spyridonidis, Alexandros https://orcid.org/0000-0003-3097-2532
Ciceri, Fabio https://orcid.org/0000-0003-0873-0123
Nagler, Arnon https://orcid.org/0000-0002-0763-1265
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
- License Information
-
More Information
Article History
Received: 30 May 2023
Revised: 26 October 2023
Accepted: 7 November 2023
First Online: 2 December 2023
Competing interests
: The authors declare no competing interests with the publication of this article. JD-A has received speaker’s honoraria from Roche, Amgen, AstraZeneca, Riemser, Lilly, Ipsen and Sobi and travel support from Gilead and Sobi. JF has received research support and speaker’s honoraria from Medac, Neovii, and Riemser. JAS declares advisory board for Medac, and speaker fees from Novartis, Mallinckrodt, Gilead and Jazz. CCrad declares consulting/speakers board fees for Abbvie, JAZZ and Medac.
: This study was approved by the general assembly of the ALWP of the EBMT.
: Patient authorization was performed via informed consent to include their data in the EBMT registry.
